In January and February, two eye drop brands were pulled from shelves after being linked to a drug-resistant bacteria strain that has been blamed for at least one fatality and numerous serious health issues. The Centers for Disease Control and Prevention (CDC) issued a warning in January asking people to stop using Delsam Pharma’s and EzriCare’s artificial tears. The following month, Global Pharma, the firm that owns the brands, announced a voluntary recall in response to an official Food and Drug Administration (FDA) recommendation.
The death toll of an outbreak related to contaminated recalled eye drops has risen and more people have lost their eyesight. In a Tuesday update, the Centers for Disease Control and Prevention reported that there have now been three deaths in addition to the one that happened in Washington state. At least eight individuals have reportedly gone blind and four people have had their eyeballs surgically removed.
The CDC is yet to provide any information about the affected patients. More than 10 different brands of artificial tears have been recalled. Most cases have been connected to Global Pharma Healthcare.
Infections are frequently found in healthcare facilities and are transmitted through poor hand hygiene, improper cleaning of medical equipment, or both. According to the CDC, the virus P. aeruginosa has resulted in an estimated 2,700 fatalities and 32,600 infections among hospitalized patients in the United States. It is also resistant to a variety of drug types. The strain has never been reported in the United States before, the CDC noted in its update.
Using Artificial Tears of EzriCare and Delsam Pharma is not recommended, according to the CDC and the FDA. Delsam’s Artificial Eye Ointment was subjected to a second recall later in February “due to possible microbial contamination.”
According to the FDA, the company failed to sufficiently test its products for bacterial contamination and improperly preserved them during packaging, which would have prevented bacterial growth in the event of contamination.
Two other businesses recalled some of their goods earlier this month. On March 1, Florida-based Apotex willingly recalled six lots of its sterile Brimonidine Tartrate Ophthalmic Solution, 0.15 percent because at least four container caps had developed cracks.
The CDC noted in its update that the strain that has been connected to the epidemic had never been documented in the country before. The FDA, state governments, and the CDC are all participating in the probe. Just a few months prior to the incident involving Global Pharma, a government commission in the Gambia criticized the Indian pharmaceutical company Maiden Pharmaceuticals for its part in the deaths of 70 kids from acute kidney injury.
Celebrity News Update— Premier Jewelry designer and manufacturer fashion house ParisJewelry.com has started manufacturing a new custom line of celebrity jewelry designs with 30% Off and Free Shipping. Replenish Your Body- Refilter Your Health with OrganicGreek.com Vitamin Bottles, Vitamins and Herbs. Become a WebFans Creator and Influencer.
Scorpionfish with chickpeas and wine polenta
